JP2023550276A5 - - Google Patents

Info

Publication number
JP2023550276A5
JP2023550276A5 JP2023526189A JP2023526189A JP2023550276A5 JP 2023550276 A5 JP2023550276 A5 JP 2023550276A5 JP 2023526189 A JP2023526189 A JP 2023526189A JP 2023526189 A JP2023526189 A JP 2023526189A JP 2023550276 A5 JP2023550276 A5 JP 2023550276A5
Authority
JP
Japan
Prior art keywords
polysaccharide
biological
disease
plant
malvarez
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023526189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550276A (ja
Filing date
Publication date
Priority claimed from GBGB2017255.7A external-priority patent/GB202017255D0/en
Application filed filed Critical
Publication of JP2023550276A publication Critical patent/JP2023550276A/ja
Publication of JP2023550276A5 publication Critical patent/JP2023550276A5/ja
Pending legal-status Critical Current

Links

JP2023526189A 2020-10-30 2021-10-29 免疫調節物質 Pending JP2023550276A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2017255.7 2020-10-30
GBGB2017255.7A GB202017255D0 (en) 2020-10-30 2020-10-30 Immunomodulatory agent
PCT/GB2021/052818 WO2022090735A1 (en) 2020-10-30 2021-10-29 Immunomodulatory agent

Publications (2)

Publication Number Publication Date
JP2023550276A JP2023550276A (ja) 2023-12-01
JP2023550276A5 true JP2023550276A5 (https=) 2024-11-05

Family

ID=73776539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023526189A Pending JP2023550276A (ja) 2020-10-30 2021-10-29 免疫調節物質

Country Status (9)

Country Link
US (1) US20240000927A1 (https=)
EP (1) EP4237470A1 (https=)
JP (1) JP2023550276A (https=)
CN (1) CN116685623A (https=)
AU (1) AU2021368506A1 (https=)
BR (1) BR112023008192A2 (https=)
CA (1) CA3196945A1 (https=)
GB (1) GB202017255D0 (https=)
WO (1) WO2022090735A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240082292A1 (en) * 2020-10-30 2024-03-14 The Queen's University Of Belfast Neurodegenerative treatment
GB2636364A (en) 2023-12-07 2025-06-18 Aramune Tech Limited Arabinogalactan
CN118256574A (zh) * 2024-01-26 2024-06-28 中国热带农业科学院热带作物品种资源研究所 一种木薯抗氧化活性多糖的制备方法及木薯多糖的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US108A (en) 1836-12-15 Braving
US4356A (en) 1846-01-15 A horace h
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
DE10064634A1 (de) * 2000-08-10 2002-02-21 Schwarzkopf Gmbh Hans Kosmetische Mittel enthaltend Malvaceae-Samenextrakte
WO2004098489A2 (en) * 2003-05-12 2004-11-18 Peptor Ltd. Compositions and methods for modulation of specific epitopes of hsp60
CN101443026A (zh) * 2006-05-11 2009-05-27 万能药生物有限公司 包含至少一种高级脂族醇和斑豆(gr iffonia simplicifolia)提取物的组合物
CA2595671A1 (en) * 2007-07-30 2009-01-30 Rajesh Kapur Method and system for producing medicinal alcohol as a prophylatic or remedy for cancer, hiv, aids and autoimmune diseases
WO2012131650A1 (en) * 2011-03-31 2012-10-04 Natarajan Herbal compositions of coccinia indica for treatment or prevention of inflammatory diseases
UY34905A (es) * 2012-07-12 2014-01-31 Abbvie Inc Proteínas de unión a il-1
TW201521714A (zh) * 2013-12-10 2015-06-16 Yih-Yuan Chiou 二苯乙烯類化物於調節動物免疫生理功能的用途
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10391138B2 (en) * 2017-07-11 2019-08-27 Muniyal Ayurvedic Research Centre Multidimensional approach for Cancer treatment

Similar Documents

Publication Publication Date Title
JP2023550276A5 (https=)
CA1142083A (en) Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing same
HUE027823T2 (hu) Immunstimuláló oligonukleotidok
CN101402944A (zh) 一种ev-71病毒毒种、人用灭活疫苗及其制备方法
JP2016512204A (ja) B型肝炎ワクチン
WO2020133817A1 (zh) 一种免疫佐剂组合物及其制备方法和应用
CN117003907A (zh) 一种提取灵芝中的多糖化合物的方法及多糖化合物的用途
CN102238959B (zh) 包含卡介菌多糖和卡介菌核酸的组合物及其在制备药剂中的应用
CN113994925A (zh) 一种轮状病毒攻毒动物模型及其建立方法
JP2023550276A (ja) 免疫調節物質
KR20150080643A (ko) Ipv―dpt 백신
CN105535964A (zh) 一种具有免疫调节作用的双链聚核苷酸—ε-聚赖氨酸—硫酸聚糖复合物及其制备使用方法
JP4523164B2 (ja) ワクチン
JP2005536588A (ja) エキナセア・アングスチホリア(Echinaceaangustifolia)の多糖
CN101972477B (zh) 磷酸锌疫苗佐剂
CN108697741B (zh) 抗病毒剂及抗病毒用食品
GB1601870A (en) Process for the separation of lipids of bacterial endotoxins
US20100310656A1 (en) Immunotherapy and prevention of autoimmune hepatitis
AU2009100451A4 (en) Medicinal formulation containing a combination of HIV Type I and HIV Type II
JPH11228602A (ja) 免疫力強化剤及び免疫力強化食品
WO2024114811A1 (zh) 一种化合物及其在Treg相关疾病的治疗中的应用
JP2019163212A (ja) スフェロイド形成促進剤の濃縮方法および精製方法。
JP3002700B2 (ja) 抗エイズウイルス剤
CN115381862A (zh) 抑制蜜蜂病毒引起的爬蜂综合征的制剂及其制备方法与应用
CN102085366B (zh) 一种复合疫苗佐剂